Friday, March 24, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home News Scan

Biodefense Headlines – May 26, 2013

by Global Biodefense Staff
May 26, 2013

Biodefense News - Headlines of the WeekDutch scientists defend patenting of Saudi coronavirus | HHS forms strategic alliance to develop new antibiotics | Universal flu jab edges closer | Saudis to send animal samples to U.S. in MERS-CoV probe | DHS Science & Technology project roundup | National preparedness: Challenges, definitions and jurisdictions | Germans find new evidence of shady Soviet-Era drug trials | Patent-protected technology ended up on FDA website, companies charge | Sen. Roberts: NBAF construction set to begin | Unusual pathogens ruled out in Alabama illness cluster | New Indian rotavirus vaccine provides hope | Government biodefense advisor profited from anthrax drug maker | A structural revolution | SARS 10 years later

See what we’re reading this week at Global Biodefense on topics like NBAF construction, the new rotavirus vaccine, emerging coronavirus patent, universal flu vaccines and more…

Dutch scientists defend patenting of Saudi coronavirus (Bloomberg) 

HHS forms strategic alliance to develop new antibiotics (HHS)

Universal flu jab edges closer (BBC News)

Saudis to send animal samples to U.S. in MERS-CoV probe (CIDRAP)

DHS Science & Technology project roundup (DHS)

National preparedness: Challenges, definitions and jurisdictions (DomPrep) 

Germans find new evidence of shady Soviet-Era drug trials (BusinessWeek) 

Patent-protected technology ended up on FDA website, companies charge (FSN)

Sen. Roberts: NBAF construction set to begin (KCUR) 

Unusual pathogens ruled out in Alabama illness cluster (CIDRAP)

New Indian rotavirus vaccine provides hope (NIH Fogarty)

Government biodefense advisor profited from anthrax drug maker (NTI GSN)

A structural revolution (Howard Hughes Medical Institute) 

SARS 10 years later (CDC)

Related Posts

Biodefense Headlines – 12 March 2023
News Scan

Biodefense Headlines – 12 March 2023

March 12, 2023
Biodefense Headlines – 24 January 2023
News Scan

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023
News Scan

Biodefense Headlines – 17 January 2023

January 17, 2023
Biodefense Headlines – 10 January 2023
News Scan

Biodefense Headlines – 10 January 2023

January 10, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC